2020
DOI: 10.1590/0037-8682-0657-2020
|View full text |Cite
|
Sign up to set email alerts
|

In silico analysis of mismatches in RT-qPCR assays of 177 SARS-CoV-2 sequences from Brazil

Abstract: Introduction: Quantitative reverse transcription polymerase chain reaction (RT-qPCR) can detect the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) in a highly specific manner. However, a decrease in the specificity of PCR assays for their targets may lead to false negative results. Methods: Here, 177 high-coverage complete SARS-CoV-2 genome sequences from 13 Brazilian states were aligned with 15 WHO recommended PCR assays. Results: Only 3 of the 15 completely aligned to all Brazilian sequences. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 18 publications
(28 reference statements)
0
3
0
Order By: Relevance
“…Although SARS-CoV-2 has a slower mutation rate than, for example, influenza (Manzanares-Meza and Medina-Contreras, 2020), it nevertheless has accrued mutations in most of the primer and probe binding sites of globally used PCR assays within a few months of the start of the pandemic. Aligning 177 genomes collected up to July 2020 from across Brazil with primer sequences of 15 of the WHO-listed SARS-CoV-2 assays revealed that only 3 assays (NIID_2019-nCoV-N, nCoV-IP4 and CN-CDC-E) had a perfect match to all 177 genomes (Santos et al, 2020). A similar study using sequence data from 375 genomes collected around the world up to April 2020 showed that only 2 out of 12 WHO-listed assays had a perfect match to all analyzed genomes (CDC-N1 and Charité RdRP) (Toms et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Although SARS-CoV-2 has a slower mutation rate than, for example, influenza (Manzanares-Meza and Medina-Contreras, 2020), it nevertheless has accrued mutations in most of the primer and probe binding sites of globally used PCR assays within a few months of the start of the pandemic. Aligning 177 genomes collected up to July 2020 from across Brazil with primer sequences of 15 of the WHO-listed SARS-CoV-2 assays revealed that only 3 assays (NIID_2019-nCoV-N, nCoV-IP4 and CN-CDC-E) had a perfect match to all 177 genomes (Santos et al, 2020). A similar study using sequence data from 375 genomes collected around the world up to April 2020 showed that only 2 out of 12 WHO-listed assays had a perfect match to all analyzed genomes (CDC-N1 and Charité RdRP) (Toms et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, for both odd and even number nucleotides in the probe, central location i.e. -1, 0, + 1 nucleotides must align with the genome sequence [ 21 , 25 ]. Notwithstanding any of the above, primers/probes having degenerate nucleotides were considered acceptable if even a single combination of nucleotide meets all the above criteria.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, for both odd and even number nucleotides in the probe, central location i.e. -1, 0, + 1 nucleotides must align with the genome sequence [ 21 , 25 ].…”
Section: Methodsmentioning
confidence: 99%